Symbol Name ID |
Ncstn
nicastrin MGI:1891700 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Gt(ROSA)26Sortm1.1(rtTA2S*M2)Whsu/Gt(ROSA)26Sor+ Ncstntm1.1Akli/Ncstntm1.1Akli Tg(tetO-cre)1Jaw/0 involves: 129 * 129S6/SvEvTac * C57BL/6 |
hydronephrosis | J:227748 |
increased urinary bladder carcinoma incidence | J:227748 | |
ureter obstruction | J:227748 | |
Ncstntm1.1Akli/Ncstntm1.1Akli Tet2tm1.1Iaai/Tet2tm1.1Iaai Tg(VAV1-cre)1Graf/0 involves: 129S/SvEv * C57BL/6 |
abnormal common myeloid progenitor cell morphology | J:196407 |
abnormal tumor pathology | J:196407 | |
enlarged spleen | J:196407 | |
increased leukemia incidence | J:196407 | |
increased leukocyte cell number | J:196407 | |
myeloid hyperplasia | J:196407 | |
premature death | J:196407 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|